These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 30739268)
1. SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy. Li F; Xu Y; Liu RL Int Urol Nephrol; 2019 Mar; 51(3):443-451. PubMed ID: 30739268 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
3. Can the free/total psa ratio predict undetected intraductal carcinoma and cribriform pattern at biopsy? Bernardino RM; Yin LB; Lajkosz K; Cockburn JG; Wettstein MS; Woon D; Nguyen DD; Sayyid R; Leão R; van der Kwast T; Fleshner N World J Urol; 2024 Nov; 42(1):651. PubMed ID: 39607443 [TBL] [Abstract][Full Text] [Related]
5. Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics. Roberts MJ; Papa N; Veerman H; de Bie K; Morton A; Franklin A; Raveenthiran S; Yaxley WJ; Donswijk ML; van der Poel HG; Samaratunga H; Wong D; Brown N; Parkinson R; Gianduzzo T; Kua B; Coughlin GD; Oprea-Lager DE; Emmett L; van Leeuwen PJ; Yaxley JW; Vis AN BJU Int; 2024 Dec; 134 Suppl 2(Suppl 2):47-55. PubMed ID: 39262180 [TBL] [Abstract][Full Text] [Related]
6. Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression. Stuchbery R; Macintyre G; Cmero M; Harewood LM; Peters JS; Costello AJ; Hovens CM; Corcoran NM Oncotarget; 2016 May; 7(21):31384-92. PubMed ID: 27120785 [TBL] [Abstract][Full Text] [Related]
7. Radical prostatectomy versus deferred treatment for localised prostate cancer. Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer. Zhang X; Ren X; Zhang S; Wang Y Exp Ther Med; 2024 Dec; 28(6):441. PubMed ID: 39583246 [TBL] [Abstract][Full Text] [Related]
9. MRI-derived tumor volume as a predictor of biochemical recurrence and adverse pathology in patients after radical prostatectomy: a propensity score matching study. Zhu X; Liu Z; He J; Li Z; He W; Lu J J Cancer Res Clin Oncol; 2023 Sep; 149(11):8853-8861. PubMed ID: 37148292 [TBL] [Abstract][Full Text] [Related]
10. The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort. Finati M; Davis M; Stephens A; Chiarelli G; Cirulli GO; Morrison C; Affas R; Sood A; Buffi N; Lughezzani G; Briganti A; Montorsi F; Carrieri G; Rogers C; Vickers AJ; Abdollah F Eur Urol Oncol; 2024 Dec; 7(6):1535-1542. PubMed ID: 38991891 [TBL] [Abstract][Full Text] [Related]
11. Periprostatic fat magnetic resonance imaging based radiomics nomogram for predicting biochemical recurrence-free survival in patients with non-metastatic prostate cancer after radical prostatectomy. Wu XH; Ke ZB; Chen ZJ; Liu WQ; Xue YT; Chen SH; Chen DN; Zheng QS; Xue XY; Wei Y; Xu N BMC Cancer; 2024 Nov; 24(1):1459. PubMed ID: 39604917 [TBL] [Abstract][Full Text] [Related]
12. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Risk Factors, and Development and Validation of Prognostic Prediction Models for Distant Metastasis in Patients With Rectal Cancer: A Study Based on the SEER Database and a Chinese Population. Zhang H; Wang H; Yao Y; Liu L; Feng F; Li H; Sun C Cancer Control; 2024; 31():10732748241303650. PubMed ID: 39579008 [TBL] [Abstract][Full Text] [Related]
15. Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation. Jayanti S; Beruni NA; Chui JN; Deng D; Liang A; Chong AS; Craig JC; Foster B; Howell M; Kim S; Mannon RB; Sapir-Pichhadze R; Scholes-Robertson NJ; Strauss AT; Jaure A; West L; Cooper TE; Wong G Cochrane Database Syst Rev; 2024 Dec; 12(12):CD014966. PubMed ID: 39698949 [TBL] [Abstract][Full Text] [Related]
16. High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT3 pathways. Zhang C; Li W; Wu F; Lu Z; Zeng P; Luo Z; Cao Y; Wen F; Li J; Chen X; Wang F Ther Adv Hematol; 2024; 15():20406207241301948. PubMed ID: 39610460 [TBL] [Abstract][Full Text] [Related]
17. The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy. Gaffney CD; Tin AL; Fainberg J; Fine S; Jibara G; Touijer K; Eastham J; Scardino P; Laudone V; Vickers AJ; Ehdaie B Cancer; 2023 Dec; 129(23):3790-3796. PubMed ID: 37584213 [TBL] [Abstract][Full Text] [Related]
18. Genetic variants of ADAM9 as potential predictors for biochemical recurrence in prostate cancer patients after receiving a radical prostatectomy. Lin YW; Wen YC; Lin CY; Hsiao CH; Ho KH; Huang HC; Chang LC; Wang SS; Yang SF; Chien MH Int J Med Sci; 2024; 21(15):2934-2942. PubMed ID: 39628685 [TBL] [Abstract][Full Text] [Related]
19. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
20. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]